+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID02824731

Comparison of Proton and Photon Radiotherapy for Brain Tumors Using Standard Clinical Doses Evaluating Side Effects and Effectiveness in Adult Patients

Led by Technische Universität Dresden · Updated on 2024-12-16

555

Participants Needed

2

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the differences in chronic toxicity between proton and photon radiotherapy for patients with various types of brain tumors who require high-dose radiotherapy. This non-randomized phase II trial aims to determine if proton therapy results in a 15% lower rate of chronic toxicity one year after treatment compared to photon therapy. The study focuses on patients with supratentorial grade IIIIV tumors primarily, with additional groups including other tumor types and patients with prior radiation exposure. Participants receive either proton or photon radiotherapy using standard doses and combined chemotherapy protocols. Treatment groups are assigned based on patient choice or treatment availability, with radiation doses ranging from 54 to 60 GyRBE for most groups under normal fractionated schedules. Patients with prior high-dose radiation receive adjusted dosing schedules. The trial includes multiple treatment arms reflecting tumor location, grade, and prior radiation exposure. During the study, participants undergo monitoring for chronic toxicity one year after radiotherapy, assessed by clinical criteria, quality of life questionnaires, and neuropsychological tests. Secondary assessments include local tumor control, overall survival, and acute toxicity at specified time points. Follow-up visits and evaluations are conducted to track outcomes and safety over at least two years, with all participants providing informed consent and meeting clinical eligibility requirements.

CONDITIONS

Brief Title

Comparison of Proton and Photon Radiotherapy of Brain Tumors (ProtoChoice-Hirn)

Research Team

M

Mechthild Krause, Prof.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here